论文部分内容阅读
川崎病(KD)又称皮肤黏膜淋巴结综合症,是一种病因未明的血管炎综合症,主要病理改变为急性中、小动脉炎,最严重的是病程中、后期发生的中、大动脉损伤,尤其是冠状动脉损害,其发生率约为2 0 %~2 5 %[1 ] 。已有大量资料证明,大剂量静脉免疫球蛋白(IVIg)治疗儿童急性川崎病较传统
Kawasaki disease (KD), also known as mucocutaneous lymph node syndrome, is an unknown etiology of vasculitis syndrome, the main pathological changes of acute middle and small arteritis, the most serious is the course of the disease, the latter part of the middle and large artery injury, In particular, coronary artery lesions, the incidence of about 20% ~ 25% [1]. There is a large body of evidence that large doses of intravenous immunoglobulin (IVIg) are more traditional treatments for acute Kawasaki disease in children